arginine and Neutropenia

arginine has been researched along with Neutropenia in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19903 (21.43)18.7374
1990's4 (28.57)18.2507
2000's5 (35.71)29.6817
2010's1 (7.14)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Bomalaski, JS; Chen, TY; Cho, SF; Feng, X; Hsiao, HH; Hsu, YT; Johnston, A; Kao, HW; Kuo, MC; Liu, TC; Liu, YC; Tsai, HJ1
Monk, PN; Moore, TA; Proctor, LM; Sanderson, SD; Taylor, SM; Woodruff, TM1
Arumugam, TV; Fairlie, DP; Proctor, LM; Reid, RC; Shiels, I; Taylor, SM1
de D'Elia, I; Diament, M; Geffner, JR; Giordano, M; Klein, D; Trevani, AS1
De Pauw, BE; Du Bois, W; Verhagen, C; Williams, KJ1
Abramson, SB; Weissmann, G1
Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH1
Basso, U; Brandes, AA; Ermani, M; Jirillo, A; Koussis, H; Lonardi, S; Monfardini, S; Paris, MK; Pasetto, LM; Tosoni, A; Vastola, F1
Abella, E; Bethencourt, C; Brunet, S; Debén, G; del Potro, E; Feliu, E; Hernández-Rivas, JM; López, R; Morgades, M; Novo, A; Oriol, A; Ortega-Rivas, F; Ortín, X; Ribera, JM; Sancho, JM; Sanz, MA; Tormo, M; Xicoy, B1
Beijnen, JH; Bussink, J; Huitema, AD; Punt, CJ; Timmer-Bonte, JN; Tjan-Heijnen, VC; van Die, CE; vd Heijden, HF1
Eguchi, K; Etou, H; Miyachi, S; Morinari, H; Nakada, K; Noda, K; Ohe, Y; Ohkuni, Y; Watanabe, K; Yamada, Y1
Biron, P; Bordessoule, D; Coiffier, B; Gisselbrecht, C; Guerci, A; Herbrecht, R; Kerneis, Y; Lederlin, P; Reyes, F; Sebban, C; Tilly, H1
Corringham, R; Corringham, S; Dhaliwal, H; Germond, C; Goss, GD; Kane, G; Rowen, J; Sinoff, C; Vincent, M1
Anderson, J; Bloomfield, CD; Cooper, MR; Ginsberg, SJ; Gottlieb, AJ; Hurd, DD; Lachant, NA1

Reviews

1 review(s) available for arginine and Neutropenia

ArticleYear
Complement split products and the pathogenesis of SLE.
    Hospital practice (Office ed.), 1988, Dec-15, Volume: 23, Issue:12

    Topics: Anaphylatoxins; Animals; Antibodies; Arginine; Biomarkers; Central Nervous System Diseases; Complement Activation; Complement C3; Complement C3a; Complement C5; Complement C5a; Complement Pathway, Alternative; Disease Models, Animal; Female; Humans; Lupus Erythematosus, Systemic; Neutropenia; Peptides; Pregnancy; Rabbits

1988

Trials

7 trial(s) available for arginine and Neutropenia

ArticleYear
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia.
    Cancer medicine, 2021, Volume: 10, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Cytarabine; Drug Administration Schedule; Female; Humans; Hydrolases; Injections, Intramuscular; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Polyethylene Glycols; Thrombocytopenia; Treatment Outcome

2021
Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Arginine; Bacterial Infections; Carbonates; Ceftazidime; Clinical Trials as Topic; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Prospective Studies; Random Allocation

1988
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome

2003
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Severity of Illness Index; Survival Analysis; Teniposide; Treatment Outcome; Vincristine

2007
Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2008, Volume: 60, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Teniposide

2008
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Teniposide; Thrombocytopenia; Treatment Outcome

1994
Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia

1992

Other Studies

6 other study(ies) available for arginine and Neutropenia

ArticleYear
Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
    International immunopharmacology, 2009, Volume: 9, Issue:6

    Topics: Animals; Arginine; Benzhydryl Compounds; Blood Pressure; Cell Degranulation; Cell Line; Complement C3a; Complement C5a; Female; Humans; Neutropenia; Neutrophils; Peptides; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Recombinant Proteins

2009
Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
    British journal of pharmacology, 2004, Volume: 142, Issue:4

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Arginine; Australia; Benzhydryl Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Injections, Intravenous; Intestinal Mucosa; Membrane Proteins; Neutropenia; Neutrophils; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Anaphylatoxin C5a; Receptors, Complement; Reperfusion Injury; Time Factors

2004
Involvement of nitric oxide in the regulation of peripheral blood leukocyte counts.
    Journal of leukocyte biology, 1995, Volume: 58, Issue:4

    Topics: Animals; Arginine; Enzyme Inhibitors; Leukocyte Count; Lymphocytes; Lymphopenia; Male; Mice; Mice, Inbred BALB C; Neutropenia; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Stereoisomerism

1995
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult

2011
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:9

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisolone; Teniposide

1996
Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Female; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Procarbazine; Teniposide; Thrombocytopenia; Vincristine

1988